"Klebsiella pneumoniae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.
| Descriptor ID |
D007711
|
| MeSH Number(s) |
B03.440.450.425.425.600 B03.660.250.150.400.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Klebsiella pneumoniae".
Below are MeSH descriptors whose meaning is more specific than "Klebsiella pneumoniae".
This graph shows the total number of publications written about "Klebsiella pneumoniae" by people in this website by year, and whether "Klebsiella pneumoniae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 2 | 3 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 2 | 4 |
| 2012 | 1 | 1 | 2 |
| 2013 | 3 | 0 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 5 | 0 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 3 | 5 |
| 2020 | 5 | 1 | 6 |
| 2021 | 2 | 2 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 5 | 5 |
| 2024 | 1 | 2 | 3 |
| 2025 | 4 | 0 | 4 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Klebsiella pneumoniae" by people in Profiles.
-
Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing Klebsiella pneumoniae in the hollow fiber infection model. Antimicrob Agents Chemother. 2026 04; 70(4):e0136525.
-
Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-?-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2026 03 04; 70(3):e0154025.
-
Phosphate sensitivity of KPC-2: a hidden variable in ?-lactamase kinetics. Antimicrob Agents Chemother. 2026 03 04; 70(3):e0106925.
-
The acquisition of rmpADC can increase virulence of classical Klebsiella pneumoniae in the absence of other hypervirulence-associated genes. mBio. 2026 Jan 14; 17(1):e0312225.
-
Antibiotics accumulate in Klebsiella pneumoniae liver abscesses but fail to eliminate antibiotic-tolerant populations. Proc Natl Acad Sci U S A. 2025 Dec 02; 122(48):e2524436122.
-
Genomic and functional analysis of rmp locus variants in Klebsiella pneumoniae. Genome Med. 2025 04 09; 17(1):36.
-
Klebsiella pneumoniae employs a type VI secretion system to overcome microbiota-mediated colonization resistance. Nat Commun. 2025 Jan 22; 16(1):940.
-
Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection. Antimicrob Agents Chemother. 2025 02 13; 69(2):e0091924.
-
Characterizing arginine, ornithine, and putrescine pathways in enteric pathobionts. Microbiologyopen. 2024 Apr; 13(2):e1408.
-
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate. Antimicrob Agents Chemother. 2024 03 06; 68(3):e0110823.